Biomerica Company Profile (OTCMKTS:BMRA)

About Biomerica

Biomerica logoBiomerica, Inc. develops, manufactures, and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions. The Company's medical diagnostic products are sold around the world in around two markets: clinical laboratories and point of care (physicians' offices and over-the-counter drugstores). The Company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications, or to measure the level of specific hormones, antibodies, antigens or other substances, which may exist in the human body in extremely small concentrations. The Company also has around two subsidiaries, Biomerica de Mexico, established for future use as a maquiladora, and BioEurope GmbH, which acts as a distributor of Biomerica products in certain markets. The Company primarily focuses on products for gastrointestinal, food intolerances, diabetes and esoteric tests.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: BMRA
  • CUSIP:
Key Metrics:
  • Previous Close: $3.20
  • 50 Day Moving Average: $2.23
  • 200 Day Moving Average: $88.03
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -103.67
  • P/E Growth: 0.00
  • Market Cap: $23.82M
  • Outstanding Shares: 7,659,000
  • Beta: 0.27
Additional Links:
Companies Related to Biomerica:

Analyst Ratings

Consensus Ratings for Biomerica (OTCMKTS:BMRA) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Biomerica (OTCMKTS:BMRA)
No equities research coverage for this company has been tracked by


Earnings History for Biomerica (OTCMKTS:BMRA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/15/2015($0.02)($0.01)ViewN/AView Earnings Details
4/15/2015($0.01)($0.02)ViewN/AView Earnings Details
1/16/2015($0.01)($0.03)ViewN/AView Earnings Details
10/17/2014($0.03)($0.03)ViewN/AView Earnings Details
9/3/2014$0.02$0.02ViewN/AView Earnings Details
1/15/2014Nov 2013($0.01)($0.03)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Biomerica (OTCMKTS:BMRA)
Current Year EPS Consensus Estimate: $-0.05 EPS
Next Year EPS Consensus Estimate: $-0.03 EPS


Dividend History for Biomerica (OTCMKTS:BMRA)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Biomerica (OTCMKTS:BMRA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/12/2016Janet MooreCFOBuy2,200$2.98$6,556.00View SEC Filing  
8/12/2016Zackary S IraniInsiderBuy3,166$2.98$9,434.68View SEC Filing  
8/11/2016Zackary S IraniCEOBuy3,700$2.88$10,656.00View SEC Filing  
8/10/2016Zackary S IraniCEOBuy1,000$2.72$2,720.00View SEC Filing  
8/9/2016Allen BarbieriDirectorBuy3,000$2.54$7,620.00View SEC Filing  
8/5/2016Francis CanoDirectorBuy16,300$2.37$38,631.00View SEC Filing  
8/3/2016Mark A SirgoDirectorBuy4,000$2.05$8,200.00View SEC Filing  
8/3/2016Zackary S IraniCEOBuy2,609$2.10$5,478.90View SEC Filing  
8/2/2016Mark A SirgoDirectorBuy8,000$1.97$15,760.00View SEC Filing  
8/1/2016Zackary S IraniCEOBuy5,400$1.88$10,152.00View SEC Filing  
5/16/2016Francis E CapitanioPresidentSell20,000$1.50$30,000.00View SEC Filing  
11/13/2015Zackary S IraniCEOBuy5,000$0.83$4,150.00View SEC Filing  
6/8/2015Zackary S IraniCEOBuy3,000$1.08$3,240.00View SEC Filing  
5/22/2015Zackary S IraniCEOBuy2,000$0.85$1,700.00View SEC Filing  
5/11/2015Zackary S IraniCEOBuy18,000$0.91$16,380.00View SEC Filing  
9/6/2012Zackary S IraniCEOBuy7,000$0.70$4,900.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Biomerica (OTCMKTS:BMRA)
DateHeadline logoHEB Gets Some Relief, ITEK Awaits Data In Dec., NYMX Abuzz, FDA Snubs AMGN (OTCMKTS:BMRA) - August 25 at 8:46 AM logoBiomerica Approved for Listing on the Nasdaq Capital Market (OTCMKTS:BMRA) - August 24 at 3:52 PM logoBiomerica, Inc. (BMRA) Cleared to List on Nasdaq CM (OTCMKTS:BMRA) - August 24 at 3:52 PM logo8:20 am Biomerica common stock has been approved for listing on the Nasdaq Capital Market, expects to commence trading on Aug 26 (OTCMKTS:BMRA) - August 24 at 12:08 PM logoBiomerica Updates Shareholders on Progress of Commercialization of Its New IBS Product (OTCMKTS:BMRA) - August 10 at 3:20 PM logoBiomerica : Forms Strategic Advisory Board (OTCMKTS:BMRA) - July 25 at 4:25 PM logoBiomerica Forms Strategic Advisory Board (OTCMKTS:BMRA) - July 25 at 3:28 PM logoBMRA: More Positive Clarity on InFoods' FDA Pathway (OTCMKTS:BMRA) - July 13 at 10:20 AM logoFDA Determines That Biomerica's Proposed InFoods® IBS Clinical Investigation Is a Nonsignificant Risk (NSR) Device Study (OTCMKTS:BMRA) - July 11 at 3:52 PM logoFDA Determines That Biomerica's Proposed InFoods(R) IBS Clinical Investigation Is a Nonsignificant Risk (NSR) Device Study (OTCMKTS:BMRA) - July 11 at 7:47 AM logoBiomerica, Inc. :BMRA-US: Earnings Analysis: Q3, 2016 By the Numbers : June 22, 2016 (OTCMKTS:BMRA) - June 22 at 11:02 AM logoBiomerica Signs Exclusive License Agreement (OTCMKTS:BMRA) - May 26 at 1:17 PM logoBiomerica Signs Exclusive License Agreement for Korean Market With Total Value of up to $8.5 Million; Licensee Makes Equity Investment of $1m in Biomerica at $3 per Share (OTCMKTS:BMRA) - May 26 at 9:09 AM logoBIOMERICA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities (OTCMKTS:BMRA) - May 26 at 8:49 AM logoBiomerica, Inc. :BMRA-US: Earnings Analysis: Q3, 2016 By the Numbers (OTCMKTS:BMRA) - April 20 at 11:18 AM logoBoard Members To Purchase Biomerica Common Stock (OTCMKTS:BMRA) - April 15 at 5:47 PM logo3rd Quarter Financials -- April 15, 2016 (OTCMKTS:BMRA) - April 15 at 5:47 PM logoBiomerica Announces Third Quarter Financial Results, Sales up 10% for Nine Months (OTCMKTS:BMRA) - April 15 at 7:47 AM logoAll Board Members of Biomerica to Purchase Biomerica Common Stock Shares in the Open Market (OTCMKTS:BMRA) - April 7 at 8:19 AM logoBIOMERICA INC Files SEC form 8-K, Other Events (OTCMKTS:BMRA) - March 16 at 6:07 AM logoBiomerica Announced That Its International Patent Application for IBS Was Reviewed by the ISA and All Claims Have Been Deemed Novel and Non-Obvious (OTCMKTS:BMRA) - March 14 at 8:19 AM logoBiomerica to Present at the ROTH Conference on March 16, 2016 (OTCMKTS:BMRA) - March 10 at 8:49 AM
News IconOxySure Launches Cardiac Safety eCommerce Store (OTCMKTS:BMRA) - March 8 at 2:30 PM
News IconOxySure Expands Sales Team with Florida Manager (OTCMKTS:BMRA) - January 28 at 1:48 PM logoBiomerica Announces Executive Advisor Appointment (OTCMKTS:BMRA) - January 20 at 3:15 PM logo2nd Quarter Financials -- January 15, 2016 (OTCMKTS:BMRA) - January 20 at 2:45 PM logoBMRA: Q2 Results, IBS Advisory Board Beefed Up Further (OTCMKTS:BMRA) - January 19 at 12:00 PM logoBiomerica Announces Second Quarter Financial Results (OTCMKTS:BMRA) - January 15 at 8:19 AM logoBiomerica Announces Executive Advisor Appointment for Medical Affairs and Research (OTCMKTS:BMRA) - January 8 at 7:11 AM logoOxySure (OXYS) Launches OxyTrac(TM) to Save Lives & Help Companies Stay Compliant (OTCMKTS:BMRA) - December 10 at 8:00 AM logoBIOMERICA INC Financials (OTCMKTS:BMRA) - December 8 at 1:16 PM logoBMRA: Q2 Results Inline. IBS May Go De Novo Pathway (OTCMKTS:BMRA) - October 20 at 10:30 AM logoBiomerica, Inc. Earnings Q1, 2016 (OTCMKTS:BMRA) - October 19 at 10:45 AM logoBiomerica Reports First Quarter Results; Sales Up Over 24% (OTCMKTS:BMRA) - October 16 at 8:19 AM logoBIOMERICA INC Files SEC form 10-Q, Quarterly Report (OTCMKTS:BMRA) - October 15 at 4:24 PM logoBiomerica Working With FDA on Submission for Its IBS Product (OTCMKTS:BMRA) - September 29 at 7:47 AM logoYear-End Results 2015 - September 1, 2015 (OTCMKTS:BMRA) - September 3 at 3:05 PM logoBMRA: Rebound of Asian Sales Driving Streak of Sequential Growth (OTCMKTS:BMRA) - September 3 at 10:30 AM logoBiomerica Announces Year End Results (OTCMKTS:BMRA) - September 1 at 8:19 AM logoBIOMERICA INC Files SEC form 10-K, Annual Report (OTCMKTS:BMRA) - August 31 at 4:24 PM logoBMRA: Additional Insight Into High-Profile IBS Product (OTCMKTS:BMRA) - July 27 at 1:45 PM logoBiomerica Announces Conference Call Regarding Its Product and Recent Developments in the Irritable Bowel Syndrome (IBS) Market (OTCMKTS:BMRA) - July 6 at 8:18 AM logoBiomerica Announces Its First Brazilian ANVISA Approvals and a New Distribution Channel in Brazil (OTCMKTS:BMRA) - June 29 at 8:19 AM


Biomerica (OTCMKTS:BMRA) Chart for Thursday, August, 25, 2016

Last Updated on 8/25/2016 by Staff